Drugs / Treosulfane
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00427999 Background | Feb 2007 → Jun 2015 | prostate cancer | Novartis Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Treosulfane | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00427999 ↗ |
| Route | Oral | “treosulfane 500mg po daily” NCT00427999 ↗ |